Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1982 Feb;21(2):347–348. doi: 10.1128/aac.21.2.347

Susceptibility of Shigella species to erythromycin.

R N Greenberg, R D Pearson, D J Innes, K T Sauer, L D Halterman, R L Guerrant
PMCID: PMC181887  PMID: 7073270

Abstract

Two of the most common causes of inflammatory enteritis are Campylobacter fetus subsp. jejuni and Shigella species. No single antimicrobial agent is recommended for treatment of both diseases. Erythromycin is used to treat C. fetus subsp. jejuni infections but has not been studied in shigellosis. For this reason, we determined the susceptibility of 22 strains of Shigella to erythromycin and found that Shigella species are susceptible to concentrations of erythromycin which are obtainable in stool.

Full text

PDF
347

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Butzler J. P., Dekeyser P., Lafontaine T. Susceptibility of related vibrios and Vibrio fetus to twelve antibiotics. Antimicrob Agents Chemother. 1974 Jan;5(1):86–89. doi: 10.1128/aac.5.1.86. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Butzler J. P., Skirrow M. B. Campylobacter enteritis. Clin Gastroenterol. 1979 Sep;8(3):737–765. [PubMed] [Google Scholar]
  3. Hartley C. L., Clements H. M., Linton K. B. Effects of cephalexin, erythromycin and clindamycin on the aerobic Gram-negative faecal flora in man. J Med Microbiol. 1978 May;11(2):125–135. doi: 10.1099/00222615-11-2-125. [DOI] [PubMed] [Google Scholar]
  4. Karmali M. A., Fleming P. C. Campylobacter enteritis in children. J Pediatr. 1979 Apr;94(4):527–533. doi: 10.1016/s0022-3476(79)80004-9. [DOI] [PubMed] [Google Scholar]
  5. Korzeniowski O. M., Barada F. A., Rouse J. D., Guerrant R. L. Value of examination for fecal leukocytes in the early diagnosis of shigellosis. Am J Trop Med Hyg. 1979 Nov;28(6):1031–1035. doi: 10.4269/ajtmh.1979.28.1031. [DOI] [PubMed] [Google Scholar]
  6. Nichols R. L., Condon R. E., DiSanto A. R. Preoperative bowel preparation. Erythromycin base serum and fecal levels following oral administration. Arch Surg. 1977 Dec;112(12):1493–1496. doi: 10.1001/archsurg.1977.01370120083010. [DOI] [PubMed] [Google Scholar]
  7. Osada Y., Une T., Ogawa H. Inhibition of cell to cell transfer of Shigella by treatment with some antibiotics. Jpn J Microbiol. 1973 May;17(3):233–235. doi: 10.1111/j.1348-0421.1973.tb00734.x. [DOI] [PubMed] [Google Scholar]
  8. Pearson R. D., Steigbigel R. T., Davis H. T., Chapman S. W. Method of reliable determination of minimal lethal antibiotic concentrations. Antimicrob Agents Chemother. 1980 Nov;18(5):699–708. doi: 10.1128/aac.18.5.699. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Tong M. J., Martin D. G., Cunningham J. J., Gunning J. J. Clinical and bacteriological evaluation of antibiotic treatment in shigellosis. JAMA. 1970 Dec 7;214(10):1841–1844. [PubMed] [Google Scholar]
  10. Vanhoof R., Gordts B., Dierickx R., Coignau H., Butzler J. P. Bacteriostatic and bactericidal activities of 24 antimicrobial agents against Campylobacter fetus subsp. jejuni. Antimicrob Agents Chemother. 1980 Jul;18(1):118–121. doi: 10.1128/aac.18.1.118. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES